Each lozenge contains: Hexylresorcinol 2.4 mg.
Pharmacology: Pharmacodynamics: Hexylresorcinol is a local anaesthetic for topical use on the mucous membranes of the mouth and throat. Mild antiseptic activity has also been demonstrated. The product base has a demulcent action.
As an antiseptic and local anaesthetic for the relief of sore throat and its associated pain.
Adults & Children 6 years & over: 1 lozenge to be dissolved slowly in the mouth every 3 hours as required up to a maximum of 12 lozenges per day.
Children under 6 years: Not Recommended.
Hexylresorcinol overdosage may cause minor gastrointestinal irritation. Treatment would be withdrawal of the product and symptomatic measures as appropriate.
Hypersensitivity to any of the ingredients.
Do not exceed the stated dose.
If symptoms persist, have not improved, or have worsened, consult a doctor or healthcare professional.
Patients with hereditary fructose intolerance, glucose-galactose malabsorption syndrome or sucrose-isomaltase deficiency should not take this medicine.
There is lack of evidence of safety of the product in human pregnancy and in animals, but hexylresorcinol has been used widely in lozenges for many years without apparent ill consequence. However, as with all medicines, caution should be exercised during pregnancy and lactation.
R02AA12 - hexylresorcinol ; Belongs to the class of antiseptics used in throat preparations.
Difflam Hextra Sore Throat Lozenges
12's
Sign Out
